KARYOPHARM THERAPEUTICS Trademark

Trademark Overview

On Thursday, August 29, 2013, a trademark application was filed for KARYOPHARM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KARYOPHARM THERAPEUTICS trademark a serial number of 86051670. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, July 7, 2021. This trademark is owned by Karyopharm Therapeutics Inc.. The KARYOPHARM THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, drugs for the treatment of cancer ((, inflammation and other diseases related to cell proliferation in humans and animals ))
karyopharm therapeutics

General Information

Serial Number86051670
Word MarkKARYOPHARM THERAPEUTICS
Filing DateThursday, August 29, 2013
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, July 7, 2021
Registration Number4676225
Registration DateTuesday, January 20, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2014

Trademark Statements

Goods and ServicesPharmaceuticals, namely, drugs for the treatment of cancer ((, inflammation and other diseases related to cell proliferation in humans and animals ))
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 9, 2013
Primary Code005
First Use Anywhere DateWednesday, November 12, 2014
First Use In Commerce DateWednesday, November 12, 2014

Trademark Owner History

Party NameKaryopharm Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewton, MA 02459
Party NameKaryopharm Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02459
Party NameKaryopharm Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events

Event DateEvent Description
Monday, September 16, 2013PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, September 2, 2013NEW APPLICATION ENTERED
Thursday, September 5, 2013TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, September 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2013ASSIGNED TO LIE
Tuesday, January 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, December 12, 2013ASSIGNED TO EXAMINER
Wednesday, December 18, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 18, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, December 18, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 18, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, December 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 19, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014USE AMENDMENT FILED
Tuesday, March 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 16, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 16, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 17, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, September 17, 2014SOU EXTENSION 1 FILED
Wednesday, October 1, 2014SOU EXTENSION 1 GRANTED
Wednesday, October 1, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 3, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, December 11, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, January 20, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 12, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, December 13, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 20, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 30, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 30, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 14, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 14, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 2, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 7, 2021REGISTERED - SEC. 15 ACKNOWLEDGED
Tuesday, January 19, 2021TEAS SECTION 8 RECEIVED
Tuesday, January 19, 2021TEAS SECTION 15 RECEIVED
Wednesday, July 7, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 7, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, October 16, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, January 20, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, July 7, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, July 7, 2021SEC. 15 ACKNOWLEDGEMENT - E-MAILED

Related Keywords

therapeutics karyopharm cell related proliferation humans animals diseases other drugs namely treatment